Skip to content
Search

Latest Stories

UK becomes first country to approve COVID booster vaccine targeting original and Omicron strains

UK first to approve Omicron COVID shot with Moderna go-ahead.

UK becomes first country to approve COVID booster vaccine targeting original and Omicron strains

The UK has become the first country to approve a so-called bivalent COVID vaccine that targets both the original strain of COVID-19 and the newer Omicron variant, British health authorities announced on Monday (15).

The Medicines and Healthcare products Regulatory Agency (MHRA) said it had given the green light to the Moderna vaccine as a sharpened tool? against the novel coronavirus after it was found to meet its standards of safety, quality and effectiveness.


In each dose of the booster vaccine, Spikevax bivalent Original/Omicron', half of the vaccine (25 micrograms) targets the original virus strain from 2020 and the other half (25 micrograms) targets Omicron, the regulator said.

"I am pleased to announce the approval of the Moderna bivalent booster vaccine, which was found in the clinical trial to provide a strong immune response against the Omicron BA.1 variant as well as the original 2020 strain," said MHRA Chief Executive Dr June Raine.

"The first generation of COVID-19 vaccines being used in the UK continue to provide important protection against the disease and save lives. What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve," she said.

The MHRA said its decision to grant approval for this booster vaccine in the UK was endorsed by the government's independent expert scientific advisory body, the Commission on Human Medicines, after carefully reviewing the evidence. The regulator said its decision is based on data from a clinical trial, which showed that a booster with the bivalent Moderna vaccine triggers a strong immune response against both Omicron (BA.1) and the original 2020 strain. In an exploratory analysis, the bivalent vaccine was also found to generate a good immune response against the Omicron sub-variants BA.4 and BA.5.

The virus, SARS-CoV-2, is continually evolving in order to evade the immunity provided by vaccines. This novel bivalent vaccine represents the next step in the development of vaccines to combat the virus, with its ability to lead to a broader immune response than the original vaccine, said Professor Sir Munir Pirmohamed, Chair of the Commission on Human Medicines.

The authorities said that safety monitoring showed that the side effects observed were the same as those seen for the original Moderna booster dose and were typically mild and self-resolving, and no serious safety concerns were identified.

The UK's independent Joint Committee on Vaccination and Immunisation (JCVI) will now advise on how this new vaccine should be rolled out as part of the country's booster vaccine deployment programme.

The vaccine has also been submitted for approval with the authorities in Australia, Canada and the European Union (EU). It is expected that the EU medicines regulator will approve the dose by next month.

Moderna CEO Stephane Bancel described the new vaccine as a "next generation COVID-19 vaccine", which will play an important role in protecting people over the winter.

"This represents the first authorisation of an Omicron-containing bivalent vaccine, further highlighting the dedication and leadership of the UK public health authorities in helping to end the COVID-19 pandemic. This bivalent vaccine has an important role to play in protecting people in the UK from COVID-19 as we enter the winter months," said Bancel.

According to official statistics, 126,504,756 vaccine doses have been administered in the UK including first and second doses as well as third and fourth booster doses rolled out on an age group basis.

More For You

The meeting between Trump and William took place at the UK ambassador's residence in Paris after the event. (Photo: Getty Images)
The meeting between Trump and William took place at the UK ambassador's residence in Paris after the event. (Photo: Getty Images)

Trump meets Prince William at Notre Dame reopening

US president-elect Donald Trump met Prince William on Saturday during the reopening ceremony of Notre Dame Cathedral in Paris.

The event marked the restoration of the historic landmark following a major fire in 2019.

Keep ReadingShow less
Princess of Wales hosts emotional Christmas service
Kate attends the "Together At Christmas" Carol Service" at Westminster Abbey in London on December 6, 2024. (Photo by ISABEL INFANTES/POOL/AFP via Getty Images)

Princess of Wales hosts emotional Christmas service

PRINCESS OF WALES, Kate Middleton, hosted a Christmas service at Westminster Abbey on Friday (6) that reflected on "the most difficult times" as she returns to public life after her cancer diagnosis.

The London carol service intended to "reflect upon the importance of love and empathy, and how much we need each other, especially in the most difficult times of our lives", according to Kensington Palace office.

Keep ReadingShow less
Rotherham sexual assault convict to be released from prison: report
Banaras Hussain

Rotherham sexual assault convict to be released from prison: report

A MAN convicted of violent sexual offences in Rotherham is set to be released from prison on licence after serving nine years of a 19-year sentence.

The crimes of Banaras Hussain, 44, included rape, indecent assault, and actual bodily harm, were part of a prolonged pattern of abuse targeting vulnerable victims, some as young as 11.

Keep ReadingShow less
Birmingham gang convicted for £2.5m Covid fraud

Birmingham gang convicted for £2.5m Covid fraud

TWELVE members of an organised crime group from Birmingham, Walsall, and Yorkshire have been found guilty of defrauding over £2.5 million in Covid support grants through fraudulent claims.

The crime group exploited non-trading businesses and stolen identities to submit multiple Covid support claims, including Bounce Back Loans, HMRC payments, and various grants set up to assist struggling businesses and individuals during the pandemic.

Keep ReadingShow less
Migrant workers key to meet housing target, warn builders
Construction workers work on building residential houses and homes at a Homes by Strata building site, in Leeds, northern England on September 4, 2024. (Photo by OLI SCARFF/AFP via Getty Images)

Migrant workers key to meet housing target, warn builders

THE UK must urgently address a construction skills shortage, including by increasing migrant worker numbers, to achieve prime minister's target of building 1.5 million homes by the end of this parliamentary term, industry leaders have warned.

The National Federation of Builders, which represents small and medium-sized contractors, highlighted the scale of the challenge, pointing to an ageing workforce and declining numbers of apprentices, the Telegraph reported.

Keep ReadingShow less